Chronotype of Patients With Diabetes and Effect on Glycaemic Control
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorUniversity of Leicester
About this trial
The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participant is willing and able to give informed consent for participation in the study
T1DM or established T2DM (>6months since diagnosis)
Male or Female
Aged 18-75 years inclusive
Disqualifiers
Participant is unwilling or unable to give informed consent
Anyone without a good command of the English language
Anyone <18 years of age and >75 years of age
BMI greater than 45 kg/m²
Trial population
Participants with established (\>6months since diagnosis) T1DM or T2DM, between the age of 18-75 years inclusive, who do not currently have a known sleep disorder (excluding OSA).
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
HBA1C level (%) measured from a blood sample
Time frame
Baseline (1 time point)Secondary outcomes
1
Mid-Sleep Time (MSF) - on both free and work days
Time frame
Baseline (1 time point)2
Glucose (mmol/L)
Time frame
Baseline (1 time point)3
Insulin (mmol/L)
Time frame
Baseline (1 time point)4
C-Peptide (ng/mL (conventional units), or nmol/L (SI))
Time frame
Baseline (1 time point)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Leicester
Lead sponsor
University Hospitals, Leicester
Collaborator
Source ClinicalTrials.gov